SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lang, B.
Right arrow Articles by Peter, H-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lang, B.
Right arrow Articles by Peter, H-H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Lupus
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus

B. Lang

University of Regensburg, Medical Centre, Department of Internal Medicine I, Regensburg, Germany

RH Straub

University of Regensburg, Medical Centre, Department of Internal Medicine I, Regensburg, Germany

S. Weber

University of Freiburg, Medical Centre, Department of Rheumatology and Clinical Immunology, Freiburg, Germany

E. Röther

University of Freiburg, Medical Centre, Department of Rheumatology and Clinical Immunology, Freiburg, Germany

M. Fleck

University of Regensburg, Medical Centre, Department of Internal Medicine I, Regensburg, Germany

H-H. Peter

University of Freiburg, Medical Centre, Department of Rheumatology and Clinical Immunology, Freiburg, Germany

In patients with systemic lupus erythematosus (SLE) and concomitant Coombs positive autoimmune haemolytic anaemia (AIHA) anticardiolipin antibodies (aCL) are found more frequently and at higher titres than in SLE patients without AIHA. In order to assess if aCL elevation is primarily associated with the underlying SLE, or with AIHA itself, we examined AIHA patients with and without underlying SLE for the presence of aCL.

aCL (IgG and IgM) were determined by ELISA in 74 SLE patients without AIHA, 22 SLE patients with AIHA, 50 patients with idiopathic AIHA (warm-reactive autoantibodies), 52 patients with idiopathic AIHA (cold-reactive autoantibodies) and 50 healthy controls.

The mean IgG and IgM aCL titres in SLE patients without AIHA (IgG 37.0 U/ml, IgM 8.9 U/ml) were significantly elevated compared with the values in healthy controls (IgG 9.1 U/ml, IgM 3.2 U/ ml; P < 0.005). The mean aCL levels in SLE patients with AIHA (IgG 53.2 U/ml, IgM 28.2 U/ml) were higher than in SLE patients without AIHA (P = 0.09 for IgG, P < 0.005 for IgM). Interestingly, the mean aCL levels of patients with idiopathic AIHA (warm-reactive autoantibody type: IgG 29.2 U/ml, IgM 19.3 U/ml; cold-reactive autoantibody type: IgG 27.4 U/ml, IgM 18.9 U/ ml) were also significantly elevated compared with healthy controls P < 0.001).

As aCL are elevated not only in SLE (with and without concomitant AIHA) but also in idiopathic AIHA it can be speculated that aCL are involved in the pathomechanism of autoantibody-induced erythrocyte destruction per se irrespective of an underlying SLE.

Key Words: anticardiolipin antibodies • autoimmune haemolytic anaemia • systemic lupus erythematosus

Lupus, Vol. 6, No. 8, 652-655 (1997)
DOI: 10.1177/096120339700600806


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
A Ruckert, H Glimm, M Lubbert, and C Grullich
Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up
Lupus, August 1, 2008; 17(8): 757 - 760.
[Abstract] [PDF]


Home page
LupusHome page
E Gomard-Mennesson, M Ruivard, M Koenig, A Woods, N Magy, J Ninet, H Rousset, G Salles, C Broussolle, and P Seve
Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases
Lupus, April 1, 2006; 15(4): 223 - 231.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
S Giannouli, M Voulgarelis, P D Ziakas, and A G Tzioufas
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
Ann Rheum Dis, February 1, 2006; 65(2): 144 - 148.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. M. Sultan, S. Begum, and D. A. Isenberg
Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems
Rheumatology, February 1, 2003; 42(2): 230 - 234.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Galindo, M. A. Khamashta, and G. R. V. Hughes
Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome
Rheumatology, September 1, 1999; 38(9): 848 - 853.
[Abstract] [Full Text] [PDF]



Advertisement